Wildcat Capital Management, LLC Quant / Systematic

CIK: 0001582384 · Show all filings

Period: Q3 2024 (← Previous) (Next →)

Filing Date: Nov 8, 2024

Total Value ($000): $204,605 (100.0% shares, 0.0% debt)

Holdings (7)

ULCC FRONTIER GROUP HLDGS INC 73.4%

Value ($000) $150,128 Shares 28,061,351 Est. Cost $5.99 Unrealized -34.7%

RLX RLX TECHNOLOGY INC 16.0%

Value ($000) $32,664 Shares 18,046,195 Est. Cost $4.05 Unrealized —

ALLO ALLOGENE THERAPEUTICS INC 4.0%

Value ($000) $8,178 Shares 2,920,787 Est. Cost $17.44 Unrealized -84.7%

URGN UROGEN PHARMA LTD 3.1%

Value ($000) $6,294 Shares 495,606 Est. Cost $34.01 Unrealized -56.4%

— SKILLZ INC 2.7%

Value ($000) $5,507 Shares 979,848 Est. Cost $19.79 Unrealized —

— KRONOS BIO INC 0.6%

Value ($000) $1,298 Shares 1,297,959 Est. Cost $29.87 Unrealized —

— SILEXION THERAPEUTICS CORP 0.3%

Value ($000) $536 Shares 1,020,852 Est. Cost $0.52 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
ULCC	FRONTIER GROUP HLDGS INC	28,061,351	$150,128	73.4%	$5.99	-34.7%	COM	35909R108
RLX	RLX TECHNOLOGY INC	18,046,195	$32,664	16.0%	$4.05	—	SPONSORED ADS	74969N103
ALLO	ALLOGENE THERAPEUTICS INC	2,920,787	$8,178	4.0%	$17.44	-84.7%	COM	019770106
URGN	UROGEN PHARMA LTD	495,606	$6,294	3.1%	$34.01	-56.4%	COM	M96088105
—	SKILLZ INC	979,848	$5,507	2.7%	$19.79	—	COM	83067L109
—	KRONOS BIO INC	1,297,959	$1,298	0.6%	$29.87	—	COM	50107A104
—	SILEXION THERAPEUTICS CORP	1,020,852	$536	0.3%	$0.52	—	SHS	G1281K106